Talimegan Tablets (Talniflumate)

Adult dose

Administer 370 mg of talniflumate orally 3 times daily. For severe cases, administer 740 mg per dose. The dose may be adjusted as appropriate according to age and symptoms.

People who regularly consume more than three glasses of alcohol per day should consult a doctor or pharmacist before taking this medication. This drug may cause gastrointestinal bleeding. This medication may affect the cardiovascular system, increasing the risk of serious cardiovascular diseases such as myocardial infarction or stroke. Particularly, those with a history of cardiovascular diseases or risk factors should be cautious, and if symptoms arise, they should consult healthcare professionals immediately. This medication can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, or perforation. The risk increases especially in elderly patients or those taking it for a long time, so they should inform healthcare professionals immediately if gastrointestinal symptoms occur. People with a history of peptic ulcers, allergies to this medication or its components, or who have had allergic reactions to aspirin or other non-steroidal anti-inflammatory drugs should not use this medication. Additionally, women who are pregnant, breastfeeding, or have severe liver, kidney, or heart disorders should not take this drug. Patients with mild to moderate liver, kidney, or heart disorders, as well as the elderly or those allergic to specific dye components, should use this medication cautiously. During treatment, patients should be vigilant for gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal pain, or hypersensitivity reactions such as skin rash and difficulty breathing, and should inform healthcare professionals immediately if these symptoms occur. This drug should be used at the lowest effective dose for the shortest duration, considering clinical needs and risks. Regular blood tests and liver and kidney function tests are necessary for long-term use. Interactions may occur when used with other anti-inflammatory analgesics or specific medications, so patients should inform healthcare professionals of any other medications they are taking. Particularly during pregnancy, near term, this medication can be harmful to the fetus and should not be taken, and caution is also necessary if breastfeeding, as the medication could potentially be passed to the baby through breast milk. This drug should not be administered to children, especially those under 12 years of age, and doses should be carefully adjusted for the elderly due to the higher possibility of side effects. Finally, this medication should be stored out of the reach of children and should not be transferred to other containers for safety.

• Gastrointestinal bleeding
• cardiovascular thrombotic reaction
• myocardial infarction
• stroke
• nausea
• vomiting
• photosensitivity
• asthma attack
• systemic fatigue due to hypotension
• hypersensitivity shock

This medication should be stored in a tightly sealed container to prevent air exposure, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance

Orange round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle